D Pharm (Israel) Management Performance Evaluation

DPRM -- Israel Stock  

ILS 430.00  0.60  0.14%

Analysis of D Pharm manpower and management performance can provide insight into D Pharm stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with D Pharm LTD future performance. Additionally see Investing Opportunities.

D Pharm Management Effectiveness

The company has return on total asset (ROA) of (42.09) % which means that it has lost $42.09 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (400.0) % meaning that it generated substantial loss on money invested by shareholders.

D Pharm Workforce Comparison

D Pharm LTD is one of the top stocks in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 22.0. D Pharm totals roughly 11.0 in number of employees claiming about 50% of stocks in Biotechnology industry.

D Pharm Profit Margins

The company has Profit Margin (PM) of (112.59) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (100.69) % which suggests for every $100 dollars of sales it generated a net operating loss of -1.01.

D Pharm Stakeholders

Golan Bitton CEO, Director
Alexander Kozak Co-Founder, CEO and Pres
David Grossman Chairman of the Board
Itschak Shrem Chairman of the Board
Aharon Schwartz Executive Chairman of the Board
Yossi Hatan Vice President - Finance
Gilad Rosenberg Vice President Clinical Development
Tamar Kfir Director
Ofir Shachaf Director
Irit Kaufman Independent Director
Ronen Rosenbloom Director
Nir Zvi Director
Assaf Segal Director
Ofer Gonen Director
Joshua Levine Director
Anat Benish External Director
Sagi Tamir External Director
Sigal Gefen External Director
Eli Cohen Director
Zohara Ran Independent Director
Ofra Yamin VP of Fin. and HR
Emanuel Kahane IR Contact Officer
Yaron Meyer General Counsel, Secretary

D Pharm Leadership

D Pharm LTD Top Executives

  Golan Bitton  CEO
CEO, Director
  Alexander Kozak  CEO
Co-Founder, CEO and Pres

D Pharm Tenure Analysis

D Pharm Employment Tenure

D Pharm employes about 11 people. The company is managed by 23 executives with total tenure of roughly 92 years, averanging almost 4.0 years of service per executive having 0.0 employee per reported executive.

D Pharm Manpower Efficiency

Return on D Pharm Manpower

Revenue Per Employee65.7 K
Revenue Per Executive31.4 K
Net Loss Per Employee74 K
Net Loss Per Executive35.4 K
Working Capital Per Employee181.8 K
Working Capital Per Executive87 K
Additionally see Investing Opportunities. Please also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Search macroaxis.com